---
{"dg-publish":true,"permalink":"/public-research-summary/insights/","updated":"2025-01-28T18:43:54-05:00"}
---

| Note Title                                                                                                                              | Note Content                                                                                                                                                                                                                                                                                                                                                |
| --------------------------------------------------------------------------------------------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| [[Research/Insights/2025-01-20 15-07-10\|2025-01-20 15-07-10]]                                                                       | <ul><li>Fasting mice for 1-2.5 days prior to muscle injury reduces muscle [[Research/Tags/Regeneration\|Regeneration]] following 7 days of [[Research/Tags/Refeeding\|Refeeding]] compared to no fasting prior to injury</li></ul>                                                                                                                                                                               |
| [[Research/Insights/2025-01-20 15-10-32\|2025-01-20 15-10-32]]                                                                       | <ul><li>Fasting mice for as little as 1 day prior to muscle injury reduces muscle [[Research/Tags/Regeneration\|Regeneration]] following 7 days of [[Research/Tags/Refeeding\|Refeeding]]</li></ul>                                                                                                                                                                                                              |
| [[Research/Insights/2025-01-20 15-18-43\|2025-01-20 15-18-43]]                                                                       | <ul><li>Fasting mice for 2.5 days prior to muscle injury reduces muscle [[Research/Tags/Regeneration\|Regeneration]] following 7 days of [[Research/Tags/Refeeding\|Refeeding]] compared to fasting for 1 day prior to injury</li></ul>                                                                                                                                                                          |
| [[Research/Insights/2025-01-20 15-24-25\|2025-01-20 15-24-25]]                                                                       | <ul><li>Fasting mice for 2.5 days prior to muscle injury reduces muscle [[Research/Tags/Regeneration\|Regeneration]] following 7 days of [[Research/Tags/Refeeding\|Refeeding]] compared to fasting for 2 days prior to injury</li></ul>                                                                                                                                                                         |
| [[Research/Insights/2025-01-20 15-29-22\|2025-01-20 15-29-22]]                                                                       | <ul><li>Fasting mice for 1 or 2 days prior to muscle injury results in the same muscle [[Research/Tags/Regeneration\|Regeneration]] following 7 days of [[Research/Tags/Refeeding\|Refeeding]]</li></ul>                                                                                                                                                                                                         |
| [[Research/Insights/2025-01-20 15-39-52\|2025-01-20 15-39-52]]                                                                       | <ul><li>Non-fasting mice can have a resting blood [[Research/Tags/Beta-Hydroxybutyrate (BHB)\|Beta-Hydroxybutyrate (BHB)]] level of ~0.4 mM</li></ul>                                                                                                                                                                                                                                                 |
| [[Research/Insights/2025-01-20 15-42-14\|2025-01-20 15-42-14]]                                                                       | <ul><li>Mice fasting for 24 hours have a blood [[Research/Tags/Beta-Hydroxybutyrate (BHB)\|Beta-Hydroxybutyrate (BHB)]] level of ~1.9 mM</li></ul>                                                                                                                                                                                                                                                    |
| [[Research/Insights/2025-01-20 15-44-11\|2025-01-20 15-44-11]]                                                                       | <ul><li>Mice have a blood [[Research/Tags/Beta-Hydroxybutyrate (BHB)\|Beta-Hydroxybutyrate (BHB)]] level of ~2.75 mM after 60 hours of [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]]</li></ul>                                                                                                                                                                                                                                |
| [[Research/Insights/2025-01-20 16-01-27\|2025-01-20 16-01-27]]                                                                       | <ul><li>The capability of mouse muscle for [[Research/Tags/Regeneration\|Regeneration]] may be reduced when blood [[Research/Tags/Beta-Hydroxybutyrate (BHB)\|Beta-Hydroxybutyrate (BHB)]] levels are ~1.9-2.25 mM at the time of injury compared to ~0.4 mM</li></ul>                                                                                                                                                            |
| [[Research/Insights/2025-01-20 16-08-05\|2025-01-20 16-08-05]]                                                                       | <ul><li>The capacity of mouse muscle for [[Research/Tags/Regeneration\|Regeneration]] may be reduced when blood [[Research/Tags/Beta-Hydroxybutyrate (BHB)\|Beta-Hydroxybutyrate (BHB)]] levels are ~2.25 mM at the time of injury compared to ~1.9-2.25 mM</li></ul>                                                                                                                                                             |
| [[Research/Insights/2025-01-20 16-46-34\|2025-01-20 16-46-34]]                                                                       | <ul><li>Mice following a [[Research/Tags/Ketogenic Diet\|Ketogenic Diet]] for 20 days have a blood [[Research/Tags/Beta-Hydroxybutyrate (BHB)\|Beta-Hydroxybutyrate (BHB)]] level of ~2.1 mM</li></ul>                                                                                                                                                                                                                              |
| [[Research/Insights/2025-01-20 16-54-40\|2025-01-20 16-54-40]]                                                                       | <ul><li>Following a [[Research/Tags/Ketogenic Diet\|Ketogenic Diet]] for 3 weeks prior to and after muscle injury reduces muscle [[Research/Tags/Regeneration\|Regeneration]] at 7 days post-injury compared to following a standard diet prior to and following injury</li></ul>                                                                                                                                     |
| [[Research/Insights/2025-01-20 18-28-57\|2025-01-20 18-28-57]]                                                                       | <ul><li>[[Research/Tags/Muscle Stem Cells (MuSCs, Satellite Stem Cells)\|Muscle Stem Cells (MuSCs, Satellite Stem Cells)]] enter a state of [[Research/Tags/Deep Quiescence\|Deep Quiescence]] at the end of 2.5-day [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] in mice</li></ul>                                                                                                                                                                                              |
| [[Research/Insights/2025-01-20 19-12-04\|2025-01-20 19-12-04]]                                                                       | <ul><li>[[Research/Tags/Muscle Stem Cells (MuSCs, Satellite Stem Cells)\|Muscle Stem Cells (MuSCs, Satellite Stem Cells)]] have reduced RNA content in mice at the end of 2.5-day [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] compared to non-fasted mice as assessed by [[Research/Tags/Pyronin Y\|Pyronin Y]]</li></ul>                                                                                                                                                 |
| [[Research/Insights/2025-01-20 19-17-51\|2025-01-20 19-17-51]]                                                                       | <ul><li>[[Research/Tags/Muscle Stem Cells (MuSCs, Satellite Stem Cells)\|Muscle Stem Cells (MuSCs, Satellite Stem Cells)]] exhibit reduced basal oxygen consumption at the end of 2.5-day [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] in mice compared with non-fasted mice</li></ul>                                                                                                                                                            |
| [[Research/Insights/2025-01-20 19-21-47\|2025-01-20 19-21-47]]                                                                       | <ul><li>Fewer [[Research/Tags/Muscle Stem Cells (MuSCs, Satellite Stem Cells)\|Muscle Stem Cells (MuSCs, Satellite Stem Cells)]] enter [[Research/Tags/S Phase\|S Phase]] when cultured ex vivo when the stem cells are isolated from mice after 2.5-day [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] mice compared to non-fasted mice as assessed by [[Research/Tags/EdU\|EdU]] incorporation</li></ul>                                                                                    |
| [[Research/Insights/2025-01-20 19-29-10\|2025-01-20 19-29-10]]                                                                       | <ul><li>Fewer [[Research/Tags/Muscle Stem Cells (MuSCs, Satellite Stem Cells)\|Muscle Stem Cells (MuSCs, Satellite Stem Cells)]] from mice undergoing 2.5-day [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] are in [[Research/Tags/S Phase\|S Phase]] at 72 hours after muscle injury compared to non-fasted mice as assessed by [[Research/Tags/EdU\|EdU]] incorporation</li></ul>                                                                                                          |
| [[Research/Insights/2025-01-20 19-40-29\|2025-01-20 19-40-29]]                                                                       | <ul><li>[[Research/Tags/Muscle Stem Cells (MuSCs, Satellite Stem Cells)\|Muscle Stem Cells (MuSCs, Satellite Stem Cells)]] are reduced in size by ~10% in mice who followed a [[Research/Tags/Ketogenic Diet\|Ketogenic Diet]] for 3 weeks compared with mice on a control diet</li></ul>                                                                                                                                                                |
| [[Research/Insights/2025-01-20 19-43-12\|2025-01-20 19-43-12]]                                                                       | <ul><li>[[Research/Tags/Muscle Stem Cells (MuSCs, Satellite Stem Cells)\|Muscle Stem Cells (MuSCs, Satellite Stem Cells)]] enter a state of [[Research/Tags/Deep Quiescence\|Deep Quiescence]] at the end of 3 weeks on a [[Research/Tags/Ketogenic Diet\|Ketogenic Diet]] in mice</li></ul>                                                                                                                                                                                            |
| [[Research/Insights/2025-01-20 19-47-43\|2025-01-20 19-47-43]]                                                                       | <ul><li>[[Research/Tags/Muscle Stem Cells (MuSCs, Satellite Stem Cells)\|Muscle Stem Cells (MuSCs, Satellite Stem Cells)]] have ~40% reduced content of [[Research/Tags/Mitochondria\|Mitochondria]] (number and/or size) in mice after following a [[Research/Tags/Ketogenic Diet\|Ketogenic Diet]] for 3 weeks compared to mice on a control diet as assessed by [[Research/Tags/MitoTracker\|MitoTracker]]</li></ul>                                                                                         |
| [[Research/Insights/2025-01-20 19-52-51\|2025-01-20 19-52-51]]                                                                       | <ul><li>Fewer [[Research/Tags/Muscle Stem Cells (MuSCs, Satellite Stem Cells)\|Muscle Stem Cells (MuSCs, Satellite Stem Cells)]] enter [[Research/Tags/S Phase\|S Phase]] when cultured ex vivo when the stem cells are isolated from mice following a [[Research/Tags/Ketogenic Diet\|Ketogenic Diet]] for 3 weeks compared to mice on a standard diet as assessed by [[Research/Tags/EdU\|EdU]] incorporation</li></ul>                                                                          |
| [[Research/Insights/2025-01-20 20-12-30\|2025-01-20 20-12-30]]                                                                       | <ul><li>[[Research/Tags/Muscle Stem Cells (MuSCs, Satellite Stem Cells)\|Muscle Stem Cells (MuSCs, Satellite Stem Cells)]] enter a state of [[Research/Tags/Deep Quiescence\|Deep Quiescence]] at the end of 1 week of 3x/day intraperitoneal injections of 200 mg/kg [[Research/Tags/Beta-Hydroxybutyrate (BHB)\|Beta-Hydroxybutyrate (BHB)]] + 200 mg/kg [[Research/Tags/Acetoacetate (AcAc)\|Acetoacetate (AcAc)]] in mice</li></ul>                                                                                                |
| [[Research/Insights/2025-01-20 20-19-43\|2025-01-20 20-19-43]]                                                                       | <ul><li>[[Research/Tags/Muscle Stem Cells (MuSCs, Satellite Stem Cells)\|Muscle Stem Cells (MuSCs, Satellite Stem Cells)]] have reduced content of [[Research/Tags/Mitochondria\|Mitochondria]] (number and/or size) in mice at the end of 7 days of 3x/day intraperitoneal 200 mg/kg [[Research/Tags/Beta-Hydroxybutyrate (BHB)\|Beta-Hydroxybutyrate (BHB)]] + 200 mg/kg [[Research/Tags/Acetoacetate (AcAc)\|Acetoacetate (AcAc)]] injections compared to control mice as assessed by [[Research/Tags/MitoTracker\|MitoTracker]] and [[Research/Tags/MitoSox\|MitoSox]]</li></ul>  |
| [[Research/Insights/2025-01-20 20-32-54\|2025-01-20 20-32-54]]                                                                       | <ul><li>[[Research/Tags/Muscle Stem Cells (MuSCs, Satellite Stem Cells)\|Muscle Stem Cells (MuSCs, Satellite Stem Cells)]] exhibit reduced basal oxygen consumption at the end of 7 days of 3x/day intraperitoneal 200 mg/kg [[Research/Tags/Beta-Hydroxybutyrate (BHB)\|Beta-Hydroxybutyrate (BHB)]] + 200 mg/kg [[Research/Tags/Acetoacetate (AcAc)\|Acetoacetate (AcAc)]] injections in mice compared with control mice</li></ul>                                                                    |
| [[Research/Insights/2025-01-20 20-37-16\|2025-01-20 20-37-16]]                                                                       | <ul><li>Fewer [[Research/Tags/Muscle Stem Cells (MuSCs, Satellite Stem Cells)\|Muscle Stem Cells (MuSCs, Satellite Stem Cells)]] enter [[Research/Tags/S Phase\|S Phase]] when cultured ex vivo when the stem cells are isolated from mice treated with 3x/day intraperitoneal injections of 200 mg/kg [[Research/Tags/Beta-Hydroxybutyrate (BHB)\|Beta-Hydroxybutyrate (BHB)]] + 200 mg/kg [[Research/Tags/Acetoacetate (AcAc)\|Acetoacetate (AcAc)]] compared to control mice as assessed by [[Research/Tags/EdU\|EdU]] incorporation</li></ul> |
| [[Research/Insights/2025-01-20 20-41-50\|2025-01-20 20-41-50]]                                                                       | <ul><li>Fewer [[Research/Tags/Muscle Stem Cells (MuSCs, Satellite Stem Cells)\|Muscle Stem Cells (MuSCs, Satellite Stem Cells)]] from mice treated with intraperitoneal injections of 200 mg/kg/day [[Research/Tags/Beta-Hydroxybutyrate (BHB)\|Beta-Hydroxybutyrate (BHB)]] + 200 mg/kg/day [[Research/Tags/Acetoacetate (AcAc)\|Acetoacetate (AcAc)]] are in [[Research/Tags/S Phase\|S Phase]] compared to control mice as assessed by Edu incorporation</li></ul>                                                          |
| [[Research/Insights/2025-01-29 10-17-06\|2025-01-29 10-17-06]]                                                                       | <ul><li>20.5-month-old mice have a lower ratio of lin-Sca1+CD45- cells to total bone marrow cells compared to 8-10-month-old mice</li></ul>                                                                                                                                                                                                                 |
| [[Research/Insights/2025-01-29 10-17-22\|2025-01-29 10-17-22]]                                                                       | <ul><li>48 hours of [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] does not reduce serum [[Research/Tags/IGF1\|IGF1]] in 24-month-old mice</li></ul>                                                                                                                                                                                                                                                     |
| [[Research/Insights/2025-01-29 10-17-26\|2025-01-29 10-17-26]]                                                                       | <ul><li>48 hours of [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] reduces serum [[Research/Tags/IGF1\|IGF1]] by ~66% in 6-month-old mice</li></ul>                                                                                                                                                                                                                                                      |
| [[Research/Insights/2025-01-29 10-17-29\|2025-01-29 10-17-29]]                                                                       | <ul><li>56% of people between 20-39 have an asymptomatic bulging [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] of the [[Research/Tags/Lumbar Spine\|Lumbar Spine]]</li></ul>                                                                                                                                                                                                                            |
| [[Research/Insights/2025-01-29 10-19-30\|2025-01-29 10-19-30]]                                                                       | <ul><li>21% of people between 20-39 have an asymptomatic herniated [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] in the [[Research/Tags/Lumbar Spine\|Lumbar Spine]]</li></ul>                                                                                                                                                                                                                          |
| [[Research/Insights/2025-01-29 10-19-56\|2025-01-29 10-19-56]]                                                                       | <ul><li>28-month old mice who have been doing 4-day [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]] cycles twice per month for 12 months have the same amount of [[Research/Tags/Lean Mass\|Lean Mass]] between FMD cycles as their non-fasted counterparts</li></ul>                                                                                                                               |
| [[Research/Insights/2025-01-29 10-20-44\|2025-01-29 10-20-44]]                                                                       | <ul><li>34% of people between 20-39 have an asymptomatic degenerated [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] of the [[Research/Tags/Lumbar Spine\|Lumbar Spine]]</li></ul>                                                                                                                                                                                                                        |
| [[Research/Insights/2025-01-29 10-22-31\|2025-01-29 10-22-31]]                                                                       | <ul><li>70% of patients who undergo intradiscal leukocyte-rich >10X [[Research/Tags/Platelet-Rich Plasma (PRP)\|Platelet-Rich Plasma (PRP)]] notice improvement within the first 12 weeks</li></ul>                                                                                                                                                                                                   |
| [[Research/Insights/2025-01-29 10-23-03\|2025-01-29 10-23-03]]                                                                       | <ul><li>72 hours of [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] around [[Research/Tags/Chemotherapy\|Chemotherapy]] is better at keeping blood [[Research/Tags/Lymphocyte\|Lymphocyte]] counts from reducing than fasting for 24 hours around chemotherapy for platinum-based doublet chemotherapy</li></ul>                                                                                                                            |
| [[Research/Insights/2025-01-29 10-24-05\|2025-01-29 10-24-05]]                                                                       | <ul><li>81% of people who have intradiscal leukocyte-rich >10X [[Research/Tags/Platelet-Rich Plasma (PRP)\|Platelet-Rich Plasma (PRP)]] are satisfied with their injection</li></ul>                                                                                                                                                                                                                  |
| [[Research/Insights/2025-01-29 10-24-28\|2025-01-29 10-24-28]]                                                                       | <ul><li>A 4-day [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]] does not negatively effect the [[Research/Tags/Lean Mass\|Lean Mass]] of mice when undergoing FMD cycles twice per month</li></ul>                                                                                                                                                                                                  |
| [[Research/Insights/2025-01-29 10-24-39\|2025-01-29 10-24-39]]                                                                       | <ul><li>A person weighing 70 kg needs as much as 13 g [[Research/Tags/Glycine\|Glycine]] per day from their diet</li></ul>                                                                                                                                                                                                                                                         |
| [[Research/Insights/2025-01-29 10-27-22\|2025-01-29 10-27-22]]                                                                       | <ul><li>85% of patients have a decrease in posterior [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] bulge size 6 months on average post-injection of an average of 23 million [[Research/Tags/Hypoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)\|Hypoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)]] into the [[Research/Tags/Nucleus Pulposus\|Nucleus Pulposus]] and [[Research/Tags/Annulus Fibrosus\|Annulus Fibrosus]] of [[Research/Tags/L4-L5\|L4-L5]] or [[Research/Tags/L5-S1\|L5-S1]]</li></ul>                                       |
| [[Research/Insights/2025-01-29 10-27-59\|2025-01-29 10-27-59]]                                                                       | <ul><li>3 days of water-only [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] is at least equivalent to a 4-day mouse [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]] in terms of its effects on [[Research/Tags/IGF1\|IGF1]] availability</li></ul>                                                                                                                                                                      |
| [[Research/Insights/2025-01-29 10-29-47\|2025-01-29 10-29-47]]                                                                       | <ul><li>4 days of [[Research/Tags/Buchinger Fasting\|Buchinger Fasting]] (max 250 kcal per day) increases plasma [[Research/Tags/IGFBP1\|IGFBP1]] by ~159%</li></ul>                                                                                                                                                                                                                                               |
| [[Research/Insights/2025-01-29 10-31-11\|2025-01-29 10-31-11]]                                                                       | <ul><li>4 days of [[Research/Tags/Buchinger Fasting\|Buchinger Fasting]] (max 250 kcal per day) reduces plasma [[Research/Tags/IGF1\|IGF1]] by ~51%</li></ul>                                                                                                                                                                                                                                                    |
| [[Research/Insights/2025-01-29 10-31-43\|2025-01-29 10-31-43]]                                                                       | <ul><li>4 days of [[Research/Tags/Buchinger Fasting\|Buchinger Fasting]] (max 250 kcal per day) reduces the plasma [[Research/Tags/IGF1-IGFBP1 Ratio\|IGF1-IGFBP1 Ratio]] by ~81%</li></ul>                                                                                                                                                                                                                                   |
| [[Research/Insights/2025-01-29 10-35-05\|2025-01-29 10-35-05]]                                                                       | <ul><li>A mouse dose in mg/kg can be divided by 12.3 to approximate an equivalent human dose in mg/kg</li></ul>                                                                                                                                                                                                                                             |
| [[Research/Insights/2025-01-29 10-35-55\|2025-01-29 10-35-55]]                                                                       | <ul><li>9 days of water-only [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] in humans is equivalent to a 3-day water-only fast in mice in terms of its effects on [[Research/Tags/IGF1\|IGF1]] availability</li></ul>                                                                                                                                                                                    |
| [[Research/Insights/2025-01-29 10-38-49\|2025-01-29 10-38-49]]                                                                       | <ul><li>A rat dose in mg/kg can be divided by 6.2 to approximate an equivalent human dose in mg/kg</li></ul>                                                                                                                                                                                                                                                |
| [[Research/Insights/2025-01-29 10-39-17\|2025-01-29 10-39-17]]                                                                       | <ul><li>A [[Research/Tags/Urolithin A\|Urolithin A]] dose of 2.5 mg/kg/day in a mouse is equivalent to 0.2 mg/kg/day in a human</li></ul>                                                                                                                                                                                                                                              |
| [[Research/Insights/2025-01-29 10-39-27\|2025-01-29 10-39-27]]                                                                       | <ul><li>A reduction in posterior [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] bulge size by >= 25% correlates with better NPS scores compared with <25% at 6 months post-injection of an average of 23 million [[Research/Tags/Hypoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)\|Hypoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)]] into the [[Research/Tags/Nucleus Pulposus\|Nucleus Pulposus]] and [[Research/Tags/Annulus Fibrosus\|Annulus Fibrosus]] of [[Research/Tags/L4-L5\|L4-L5]] or [[Research/Tags/L5-S1\|L5-S1]]</li></ul>    |
| [[Research/Insights/2025-01-29 10-40-59\|2025-01-29 10-40-59]]                                                                       | <ul><li>A [[Research/Tags/Urolithin A\|Urolithin A]] dose greater than 0.2 mg/kg may relieve pain from constriction of the [[Research/Tags/Sciatic Nerve\|Sciatic Nerve]]</li></ul>                                                                                                                                                                                                                                 |
| [[Research/Insights/2025-01-29 10-41-13\|2025-01-29 10-41-13]]                                                                       | <ul><li>A [[Research/Tags/Urolithin A\|Urolithin A]] dose of 25 mg/kg/day in a rat equates to 4 mg/kg/day in a human</li></ul>                                                                                                                                                                                                                                                         |
| [[Research/Insights/2025-01-29 10-42-32\|2025-01-29 10-42-32]]                                                                       | <ul><li>A [[Research/Tags/Urolithin A\|Urolithin A]] dose of 250 mg/kg/day in a mouse equates to 20.3 mg/kg/day in a human</li></ul>                                                                                                                                                                                                                                                   |
| [[Research/Insights/2025-01-29 10-43-15\|2025-01-29 10-43-15]]                                                                       | <ul><li>A [[Research/Tags/Urolithin A\|Urolithin A]] dose of 250 mg/kg/day is likely better than a dose of 50 mg/kg/day at reducing the pain from knee [[Research/Tags/Osteoarthritis\|Osteoarthritis]] in mice when taken for 8 weeks after the induction of experimental arthritis at 4 months of age</li></ul>                                                                                                    |
| [[Research/Insights/2025-01-29 10-43-59\|2025-01-29 10-43-59]]                                                                       | <ul><li>[[Research/Tags/Alternate-Day Fasting (ADF)\|Alternate-Day Fasting (ADF)]] for 9 months increases the number of Lin-Sca1+CD45- [[Research/Tags/Very Small Embryonic-Like Stem Cells (VSELs)\|Very Small Embryonic-Like Stem Cells (VSELs)]] compared to no fasting in the bone marrow of 10-month-old mice</li></ul>                                                                                                                                       |
| [[Research/Insights/2025-01-29 10-44-28\|2025-01-29 10-44-28]]                                                                       | <ul><li>[[Research/Tags/Alternate-Day Fasting (ADF)\|Alternate-Day Fasting (ADF)]] for 9 months increases the ratio of Lin-Sca1+CD45- [[Research/Tags/Very Small Embryonic-Like Stem Cells (VSELs)\|Very Small Embryonic-Like Stem Cells (VSELs)]] to total [[Research/Tags/Bone Marrow Mononuclear Cells (BMMNCs)\|Bone Marrow Mononuclear Cells (BMMNCs)]] compared to no fasting in the bone marrow of 10-month-old mice</li></ul>                                                                                    |
| [[Research/Insights/2025-01-29 10-45-52\|2025-01-29 10-45-52]]                                                                       | <ul><li>[[Research/Tags/Chemical Radiculitis\|Chemical Radiculitis]] can be resolved with intradiscal 10X [[Research/Tags/Platelet-Rich Plasma (PRP)\|Platelet-Rich Plasma (PRP)]] within two weeks</li></ul>                                                                                                                                                                                                                             |
| [[Research/Insights/2025-01-29 10-45-55\|2025-01-29 10-45-55]]                                                                       | <ul><li>[[Research/Tags/Chemical Radiculitis\|Chemical Radiculitis]] can be resolved with an epidural</li></ul>                                                                                                                                                                                                                                                                                 |
| [[Research/Insights/2025-01-29 10-45-58\|2025-01-29 10-45-58]]                                                                       | <ul><li>[[Research/Tags/Chemical Radiculitis\|Chemical Radiculitis]] can be present with negative [[Research/Tags/Straight-Leg Raise Test\|Straight-Leg Raise Test]]</li></ul>                                                                                                                                                                                                                                                         |
| [[Research/Insights/2025-01-29 10-46-01\|2025-01-29 10-46-01]]                                                                       | <ul><li>[[Research/Tags/Chemical Radiculitis\|Chemical Radiculitis]] can be worse while standing</li></ul>                                                                                                                                                                                                                                                                                      |
| [[Research/Insights/2025-01-29 10-46-05\|2025-01-29 10-46-05]]                                                                       | <ul><li>[[Research/Tags/Chemical Radiculitis\|Chemical Radiculitis]] can affect both legs when a tear is on one side of the [[Research/Tags/Annulus Fibrosus\|Annulus Fibrosus]]</li></ul>                                                                                                                                                                                                                                      |
| [[Research/Insights/2025-01-29 10-46-08\|2025-01-29 10-46-08]]                                                                       | <ul><li>[[Research/Tags/Chemical Radiculitis\|Chemical Radiculitis]] can affect both legs when a tear is in the middle of the [[Research/Tags/Annulus Fibrosus\|Annulus Fibrosus]]</li></ul>                                                                                                                                                                                                                                    |
| [[Research/Insights/2025-01-29 10-46-32\|2025-01-29 10-46-32]]                                                                       | <ul><li>Daily intraperitoneal injections of 2.5 mg/kg [[Research/Tags/Urolithin A\|Urolithin A]] in mice reduce pain from chronic [[Research/Tags/Sciatic Nerve\|Sciatic Nerve]] constriction compared to mice not administered urolithin A</li></ul>                                                                                                                                                               |
| [[Research/Insights/2025-01-29 10-47-07\|2025-01-29 10-47-07]]                                                                       | <ul><li>Circulating [[Research/Tags/IGF1\|IGF1]] is reduced by ~75% at the end of 72-hour [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] compared with non-fasting mice</li></ul>                                                                                                                                                                                                                        |
| [[Research/Insights/2025-01-29 10-47-58\|2025-01-29 10-47-58]]                                                                       | <ul><li>[[Research/Tags/Chemical Radiculitis\|Chemical Radiculitis]] can be worse when sitting</li></ul>                                                                                                                                                                                                                                                                                        |
| [[Research/Insights/2025-01-29 10-51-11\|2025-01-29 10-51-11]]                                                                       | <ul><li>A tear in the [[Research/Tags/Annulus Fibrosus\|Annulus Fibrosus]] may require [[Research/Tags/Contrast\|Contrast]]-enhanced [[Research/Tags/Magnetic Resonance Imaging (MRI)\|Magnetic Resonance Imaging (MRI)]] in order to be seen</li></ul>                                                                                                                                                                                                             |
| [[Research/Insights/2025-01-29 10-52-06\|2025-01-29 10-52-06]]                                                                       | <ul><li>Daily intraperitoneal injections of 2.5 mg/kg [[Research/Tags/Urolithin A\|Urolithin A]] in mice reduce the pain-related behavioral deficits from chronic [[Research/Tags/Sciatic Nerve\|Sciatic Nerve]] constriction compared to mice not administered urolithin A when injections begin immediately after constriction surgery</li></ul>                                                                  |
| [[Research/Insights/2025-01-29 10-52-14\|2025-01-29 10-52-14]]                                                                       | <ul><li>[[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] height is not changed at 12 months after intradiscal injection of 10±5 million [[Research/Tags/Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)\|Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)]]</li></ul>                                                                                                                                                               |
| [[Research/Insights/2025-01-29 10-52-31\|2025-01-29 10-52-31]]                                                                       | <ul><li>Excluding input from dietary proteins, there is a net balance of -11.5 grams of [[Research/Tags/Glycine\|Glycine]] per day for a person weighing 70 kg</li></ul>                                                                                                                                                                                                           |
| [[Research/Insights/2025-01-29 10-52-38\|2025-01-29 10-52-38]]                                                                       | <ul><li>[[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] for 10 days reduces circulating [[Research/Tags/IGF1\|IGF1]] by 75%</li></ul>                                                                                                                                                                                                                                                                     |
| [[Research/Insights/2025-01-29 10-53-18\|2025-01-29 10-53-18]]                                                                       | <ul><li>Ex-vivo treatment of cells from mouse bone marrow with siRNA targeting the [[Research/Tags/Protein Kinase A (PKA)\|Protein Kinase A (PKA)]] catalytic subunit ([[Research/Tags/Protein Kinase A Catalytic Subunit (PKACα)\|Protein Kinase A Catalytic Subunit (PKACα)]]) does not affect the total number of cells compared to untreated cells</li></ul>                                                                                            |
| [[Research/Insights/2025-01-29 10-53-58\|2025-01-29 10-53-58]]                                                                       | <ul><li>[[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] bulges, disc protrusions, and discs with normal contours but abnormal heights and-or T2 signal intensities on [[Research/Tags/Magnetic Resonance Imaging (MRI)\|Magnetic Resonance Imaging (MRI)]] are highly likely to indicate the presence of a tear in the inner [[Research/Tags/Annulus Fibrosus\|Annulus Fibrosus]]</li></ul>                                                                   |
| [[Research/Insights/2025-01-29 10-54-58\|2025-01-29 10-54-58]]                                                                       | <ul><li>[[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] hydration is increased by an average of 16% at 12 months after intradiscal injection of 10±5 million [[Research/Tags/Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)\|Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)]]</li></ul>                                                                                                                                         |
| [[Research/Insights/2025-01-29 10-55-56\|2025-01-29 10-55-56]]                                                                       | <ul><li>[[Research/Tags/Discopathy\|Discopathy]] should be the term used to collectively refer to [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] bulges and disc protrusions and discs with normal contours but abnormal heights and-or T2 signal intensities on [[Research/Tags/Magnetic Resonance Imaging (MRI)\|Magnetic Resonance Imaging (MRI)]]</li></ul>                                                                                        |
| [[Research/Insights/2025-01-29 10-57-27\|2025-01-29 10-57-27]]                                                                       | <ul><li>Ex vivo treatment of cells from mouse bone marrow with siRNA targeting the [[Research/Tags/Protein Kinase A (PKA)\|Protein Kinase A (PKA)]] catalytic subunit ([[Research/Tags/Protein Kinase A Catalytic Subunit (PKACα)\|Protein Kinase A Catalytic Subunit (PKACα)]]) increases the ratio of [[Research/Tags/Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)\|Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)]] to total cells compared with untreated cells</li></ul>                              |
| [[Research/Insights/2025-01-29 10-57-40\|2025-01-29 10-57-40]]                                                                       | <ul><li>[[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] for 10 days after 3 days of [[Research/Tags/Calorie Restriction\|Calorie Restriction]] reduces serum [[Research/Tags/IGF1\|IGF1]] by at least 75%</li></ul>                                                                                                                                                                                                                          |
| [[Research/Insights/2025-01-29 11-00-47\|2025-01-29 11-00-47]]                                                                       | <ul><li>[[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] for 3 days after 3 days of [[Research/Tags/Calorie Restriction\|Calorie Restriction]] reduces serum [[Research/Tags/IGF1\|IGF1]] by at least 41%</li></ul>                                                                                                                                                                                                                           |
| [[Research/Insights/2025-01-29 11-01-02\|2025-01-29 11-01-02]]                                                                       | <ul><li>[[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] for 3 days reduces serum [[Research/Tags/IGF1\|IGF1]] by 42%</li></ul>                                                                                                                                                                                                                                                                            |
| [[Research/Insights/2025-01-29 11-01-45\|2025-01-29 11-01-45]]                                                                       | <ul><li>[[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] for 3 days reduces serum [[Research/Tags/IGF1\|IGF1]] by 54%</li></ul>                                                                                                                                                                                                                                                                            |
| [[Research/Insights/2025-01-29 11-02-36\|2025-01-29 11-02-36]]                                                                       | <ul><li>[[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] for 4 days reduces circulating [[Research/Tags/IGF1\|IGF1]] levels by 59%</li></ul>                                                                                                                                                                                                                                                               |
| [[Research/Insights/2025-01-29 11-02-49\|2025-01-29 11-02-49]]                                                                       | <ul><li>[[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] for 4 days reduces serum [[Research/Tags/IGF1\|IGF1]] levels by 59%</li></ul>                                                                                                                                                                                                                                                                     |
| [[Research/Insights/2025-01-29 11-03-54\|2025-01-29 11-03-54]]                                                                       | <ul><li>[[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] for 5 days after 3 days of [[Research/Tags/Calorie Restriction\|Calorie Restriction]] reduces serum [[Research/Tags/IGF1\|IGF1]] by at least 53%</li></ul>                                                                                                                                                                                                                           |
| [[Research/Insights/2025-01-29 11-04-24\|2025-01-29 11-04-24]]                                                                       | <ul><li>[[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] for 5 days reduces circulating [[Research/Tags/IGF1\|IGF1]] levels by 53-64%</li></ul>                                                                                                                                                                                                                                                            |
| [[Research/Insights/2025-01-29 11-04-37\|2025-01-29 11-04-37]]                                                                       | <ul><li>[[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] for 5 days reduces serum [[Research/Tags/IGF1\|IGF1]] by 64%</li></ul>                                                                                                                                                                                                                                                                            |
| [[Research/Insights/2025-01-29 11-05-25\|2025-01-29 11-05-25]]                                                                       | <ul><li>[[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] for 7 days after 3 days of [[Research/Tags/Calorie Restriction\|Calorie Restriction]] reduces serum [[Research/Tags/IGF1\|IGF1]] by at least 62%</li></ul>                                                                                                                                                                                                                           |
| [[Research/Insights/2025-01-29 11-06-02\|2025-01-29 11-06-02]]                                                                       | <ul><li>[[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] for 3 days reduces circulating [[Research/Tags/IGF1\|IGF1]] levels by 41-54%</li></ul>                                                                                                                                                                                                                                                            |
| [[Research/Insights/2025-01-29 11-23-24\|2025-01-29 11-23-24]]                                                                       | <ul><li>[[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] for 7 days reduces circulating [[Research/Tags/IGF1\|IGF1]] by 62%</li></ul>                                                                                                                                                                                                                                                                      |
| [[Research/Insights/2025-01-29 11-24-22\|2025-01-29 11-24-22]]                                                                       | <ul><li>[[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] for 72 hours reduces circulating [[Research/Tags/IGF1\|IGF1]] levels by 70-75% in mice</li></ul>                                                                                                                                                                                                                                                  |
| [[Research/Insights/2025-01-29 11-24-44\|2025-01-29 11-24-44]]                                                                       | <ul><li>[[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] for 72 hours induces symmetric [[Research/Tags/Self-Renewal\|Self-Renewal]] of mouse [[Research/Tags/Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)\|Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)]]</li></ul>                                                                                                                                                                                            |
| [[Research/Insights/2025-01-29 11-25-02\|2025-01-29 11-25-02]]                                                                       | <ul><li>[[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] for 9 days after 3 days of [[Research/Tags/Calorie Restriction\|Calorie Restriction]] reduces serum [[Research/Tags/IGF1\|IGF1]] by at least 71%</li></ul>                                                                                                                                                                                                                           |
| [[Research/Insights/2025-01-29 11-26-23\|2025-01-29 11-26-23]]                                                                       | <ul><li>[[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] for 9 days reduces circulating [[Research/Tags/IGF1\|IGF1]] by 71%</li></ul>                                                                                                                                                                                                                                                                      |
| [[Research/Insights/2025-01-29 11-46-14\|2025-01-29 11-46-14]]                                                                       | <ul><li>[[Research/Tags/Muscle Stem Cells (MuSCs, Satellite Stem Cells)\|Muscle Stem Cells (MuSCs, Satellite Stem Cells)]] are reduced in size by ~10% in mice by the end of 1 week of 3x/day intraperitoneal 200 mg/kg racemic [[Research/Tags/Racemic Beta-Hydroxybutyrate (DL-BHB)\|Racemic Beta-Hydroxybutyrate (DL-BHB)]] and 200 mg/kg [[Research/Tags/Acetoacetate (AcAc)\|Acetoacetate (AcAc)]] injections compared to control mice</li></ul>                                                              |
| [[Research/Insights/2025-01-30 11-55-39\|2025-01-30 11-55-39]]                                                                       | <ul><li>Injecting [[Research/Tags/IGF1\|IGF1]] into fasting mice prevented an increase in the number of [[Research/Tags/Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)\|Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)]] at 72 hours of [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] compared with 72-hour-fasted mice that were not injected with IGF1 while fasting</li></ul>                                                                         |
| [[Research/Insights/2025-01-30 12-05-44\|2025-01-30 12-05-44]]                                                                       | <ul><li>Injecting [[Research/Tags/IGF1\|IGF1]] into fasting mice prevented an increase in the ratio of [[Research/Tags/Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)\|Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)]] to total bone marrow cells at 72 hours of [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] compared with 72-hour-fasted mice that were not injected with IGF1 while fasting</li></ul>                                               |
| [[Research/Insights/2025-01-30 12-06-46\|2025-01-30 12-06-46]]                                                                       | <ul><li>Injecting leukocyte-rich >10X [[Research/Tags/Platelet-Rich Plasma (PRP)\|Platelet-Rich Plasma (PRP)]] into a pain-generating [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] is successful in 70% of patients as assessed by NRS pain score, FRI, and patient satisfaction</li></ul>                                                                                                                           |
| [[Research/Insights/2025-01-30 12-10-44\|2025-01-30 12-10-44]]                                                                       | <ul><li>It takes 48-72 hours of [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] for [[Research/Tags/Protein Kinase A (PKA)\|Protein Kinase A (PKA)]] activity to decrease in the bone marrow cells of mice</li></ul>                                                                                                                                                                                                        |
| [[Research/Insights/2025-01-30 12-11-56\|2025-01-30 12-11-56]]                                                                       | <ul><li>[[Research/Tags/Back Pain\|Back Pain]] in the [[Research/Tags/Lumbar Spine\|Lumbar Spine]] is reduced by an average of 62% at 3 months after injection of 10±5 million [[Research/Tags/Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)\|Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)]] into a non-torn [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] at [[Research/Tags/L5-S1\|L5-S1]], [[Research/Tags/L4-L5\|L4-L5]], or both levels</li></ul>                                                                    |
| [[Research/Insights/2025-01-30 12-13-47\|2025-01-30 12-13-47]]                                                                       | <ul><li>[[Research/Tags/Back Pain\|Back Pain]] in the [[Research/Tags/Lumbar Spine\|Lumbar Spine]] is reduced by an average of 69% at 6 months after injection of 10±5 million [[Research/Tags/Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)\|Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)]] into a non-torn [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] at [[Research/Tags/L5-S1\|L5-S1]], [[Research/Tags/L4-L5\|L4-L5]], or both levels</li></ul>                                                                    |
| [[Research/Insights/2025-01-30 12-15-27\|2025-01-30 12-15-27]]                                                                       | <ul><li>[[Research/Tags/Back Pain\|Back Pain]] in the [[Research/Tags/Lumbar Spine\|Lumbar Spine]] is reduced by an average of 71% at 12 months after injection of 10±5 million [[Research/Tags/Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)\|Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)]] into a non-torn [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] at [[Research/Tags/L5-S1\|L5-S1]], [[Research/Tags/L4-L5\|L4-L5]], or both levels</li></ul>                                                                   |
| [[Research/Insights/2025-01-30 12-18-13\|2025-01-30 12-18-13]]                                                                       | <ul><li>Mice eat ~4g food per day when they are 4 months old</li></ul>                                                                                                                                                                                                                                                                                      |
| [[Research/Insights/2025-01-30 12-22-21\|2025-01-30 12-22-21]]                                                                       | <ul><li>Mice have a blood [[Research/Tags/Beta-Hydroxybutyrate (BHB)\|Beta-Hydroxybutyrate (BHB)]] level of ~2.25 mM after 48 hours of [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]]</li></ul>                                                                                                                                                                                                                                |
| [[Research/Insights/2025-01-30 12-28-26\|2025-01-30 12-28-26]]                                                                       | <ul><li>Plasma levels of [[Research/Tags/IGF1\|IGF1]] are reduced by 70% in mice after 72-hour [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] compared with non-fasting mice</li></ul>                                                                                                                                                                                                                   |
| [[Research/Insights/2025-01-30 12-47-40\|2025-01-30 12-47-40]]                                                                       | <ul><li>Mice weigh ~30g at 4 months of age</li></ul>                                                                                                                                                                                                                                                                                                        |
| [[Research/Insights/2025-01-30 13-50-44\|2025-01-30 13-50-44]]                                                                       | <ul><li>Rats weigh up to ~255g when they are 8 weeks old</li></ul>                                                                                                                                                                                                                                                                                          |
| [[Research/Insights/2025-01-30 13-51-06\|2025-01-30 13-51-06]]                                                                       | <ul><li>Plasma levels of [[Research/Tags/IGFBP3\|IGFBP3]] are decreased by 42% in mice after 72-hour [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] compared with non-fasting mice</li></ul>                                                                                                                                                                                                               |
| [[Research/Insights/2025-01-30 13-51-11\|2025-01-30 13-51-11]]                                                                       | <ul><li>Plasma levels of [[Research/Tags/IGFBP1\|IGFBP1]] are increased by 11.4-fold after 72-hour [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] compared with non-fasted mice</li></ul>                                                                                                                                                                                                                  |
| [[Research/Insights/2025-01-30 13-53-46\|2025-01-30 13-53-46]]                                                                       | <ul><li>[[Research/Tags/Refeeding\|Refeeding]] after an [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]] cycle causes a reduction in [[Research/Tags/Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)\|Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)]] [[Research/Tags/Senescent Cells\|Senescent Cells]] specifically due to [[Research/Tags/Apoptosis\|Apoptosis]]</li></ul>                                                                                                                                 |
| [[Research/Insights/2025-01-30 13-54-39\|2025-01-30 13-54-39]]                                                                       | <ul><li>[[Research/Tags/Refeeding\|Refeeding]] after a [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]] causes [[Research/Tags/Senescent Cells\|Senescent Cells]] of various types throughout the body to die off</li></ul>                                                                                                                                                                                                         |
| [[Research/Insights/2025-01-30 13-56-42\|2025-01-30 13-56-42]]                                                                       | <ul><li>Reducing expression of th [[Research/Tags/Protein Kinase A Catalytic Subunit (PKACα)\|Protein Kinase A Catalytic Subunit (PKACα)]] in mouse bone marrow causes proliferation of [[Research/Tags/Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)\|Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)]]</li></ul>                                                                                                                                                     |
| [[Research/Insights/2025-01-30 13-58-04\|2025-01-30 13-58-04]]                                                                       | <ul><li>Rats eat up to ~23 grams of food per day at 6-7 weeks of age</li></ul>                                                                                                                                                                                                                                                                              |
| [[Research/Insights/2025-01-30 13-58-41\|2025-01-30 13-58-41]]                                                                       | <ul><li>Rats eat up to ~23 grams of food per day at 6-12 weeks of age</li></ul>                                                                                                                                                                                                                                                                             |
| [[Research/Insights/2025-01-30 13-59-03\|2025-01-30 13-59-03]]                                                                       | <ul><li>Rats eat up to ~22 grams of food per day at 11-12 weeks of age</li></ul>                                                                                                                                                                                                                                                                            |
| [[Research/Insights/2025-01-30 14-02-08\|2025-01-30 14-02-08]]                                                                       | <ul><li>[[Research/Tags/Neuropathy\|Neuropathy]] and/or [[Research/Tags/Chemical Radiculitis\|Chemical Radiculitis]] can be resolved within 12 weeks of injecting 10X [[Research/Tags/Platelet-Rich Plasma (PRP)\|Platelet-Rich Plasma (PRP)]] into the [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]]</li></ul>                                                                                                                                                                     |
| [[Research/Insights/2025-01-30 14-05-11\|2025-01-30 14-05-11]]                                                                       | <ul><li>Serum [[Research/Tags/IGF1\|IGF1]] levels are reduced to ~200 ng/mL in mice during a 4-day [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]]</li></ul>                                                                                                                                                                                                                                   |
| [[Research/Insights/2025-01-30 14-05-50\|2025-01-30 14-05-50]]                                                                       | <ul><li>[[Research/Tags/Refeeding\|Refeeding]] causes [[Research/Tags/Apoptosis\|Apoptosis]] in [[Research/Tags/Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)\|Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)]] [[Research/Tags/Senescent Cells\|Senescent Cells]] following two consecutive [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]] cycles</li></ul>                                                                                                                                               |
| [[Research/Insights/2025-01-30 14-07-34\|2025-01-30 14-07-34]]                                                                       | <ul><li>[[Research/Tags/Refeeding\|Refeeding]] with ~0.4 g/kg protein after 5-day [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] allows serum [[Research/Tags/IGF1\|IGF1]] levels to continue decreasing when refeeding with 552-799 kcal/day (10.8 kcal/kg) but not 1797-2579 kcal/day (35.1 kcal/kg)</li></ul>                                                                                                                  |
| [[Research/Insights/2025-01-30 14-08-07\|2025-01-30 14-08-07]]                                                                       | <ul><li>[[Research/Tags/Sciatica\|Sciatica]] is not significantly reduced at 3 months after after injection of 10±5 million [[Research/Tags/Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)\|Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)]] into a non-torn [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] at [[Research/Tags/L5-S1\|L5-S1]], [[Research/Tags/L4-L5\|L4-L5]], or both levels</li></ul>                                                                                          |
| [[Research/Insights/2025-01-30 14-12-07\|2025-01-30 14-12-07]]                                                                       | <ul><li>[[Research/Tags/Sciatica\|Sciatica]] is reduced by an average of 79% at 6 months after injection of 10±5 million [[Research/Tags/Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)\|Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)]] into the [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]]</li></ul>                                                                                                                                            |
| [[Research/Insights/2025-01-30 14-13-16\|2025-01-30 14-13-16]]                                                                       | <ul><li>[[Research/Tags/Sciatica\|Sciatica]] is reduced by an average of 86% at 12 months after injection of 10±5 million [[Research/Tags/Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)\|Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)]] into the [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]]</li></ul>                                                                                                                                           |
| [[Research/Insights/2025-01-30 14-13-57\|2025-01-30 14-13-57]]                                                                       | <ul><li>[[Research/Tags/Senescent Cells\|Senescent Cells]] accumulate throughout the body with [[Research/Tags/Aging\|Aging]]</li></ul>                                                                                                                                                                                                                                                                         |
| [[Research/Insights/2025-01-30 14-14-19\|2025-01-30 14-14-19]]                                                                       | <ul><li>Serum [[Research/Tags/IGF1\|IGF1]] levels are reduced by ~45% in mice during a 4-day [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]]</li></ul>                                                                                                                                                                                                                                         |
| [[Research/Insights/2025-01-30 14-15-44\|2025-01-30 14-15-44]]                                                                       | <ul><li>Serum [[Research/Tags/IGFBP1\|IGFBP1]] levels are increased by ~800% in mice during a 4-day [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]]</li></ul>                                                                                                                                                                                                                                    |
| [[Research/Insights/2025-01-30 14-16-21\|2025-01-30 14-16-21]]                                                                       | <ul><li>Taking [[Research/Tags/Urolithin A\|Urolithin A]] with high-protein yogurt (17 grams) in the morning while fasting does not impact the bioavailability of urolithin A at doses of 500 mg or 1000 mg</li></ul>                                                                                                                                                                  |
| [[Research/Insights/2025-01-30 14-20-22\|2025-01-30 14-20-22]]                                                                       | <ul><li>The % of mouse [[Research/Tags/Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)\|Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)]] in [[Research/Tags/G0 Phase\|G0 Phase]] is reduced at the end of 72-hour [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] compared with non-fasting mice</li></ul>                                                                                                                                                      |
| [[Research/Insights/2025-01-30 14-21-44\|2025-01-30 14-21-44]]                                                                       | <ul><li>The % of mouse [[Research/Tags/Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)\|Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)]] in [[Research/Tags/G1 Phase\|G1 Phase]] is increased at the end of 72-hour [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] compared with non-fasting mice</li></ul>                                                                                                                                                    |
| [[Research/Insights/2025-01-30 14-22-58\|2025-01-30 14-22-58]]                                                                       | <ul><li>The % of mouse [[Research/Tags/Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)\|Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)]] in [[Research/Tags/S-G2-M\|S-G2-M]] is increased at the end of 72-hour [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] compared with non-fasting mice</li></ul>                                                                                                                                                      |
| [[Research/Insights/2025-01-30 14-23-59\|2025-01-30 14-23-59]]                                                                       | <ul><li>The % of cas3+ [[Research/Tags/Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)\|Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)]] in 22-month-old mice is not affected by a [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]] cycle</li></ul>                                                                                                                                                                           |
| [[Research/Insights/2025-01-30 14-24-58\|2025-01-30 14-24-58]]                                                                       | <ul><li>The % of cas3+ [[Research/Tags/Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)\|Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)]] increases from ~1% to ~3% in the bone marrow of 22-month-old mice at 24 hours after [[Research/Tags/Refeeding\|Refeeding]] following two consecutive [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]] cycles</li></ul>                                                                                        |
| [[Research/Insights/2025-01-30 14-25-13\|2025-01-30 14-25-13]]                                                                       | <ul><li>The % of cas3+p16+ [[Research/Tags/Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)\|Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)]] in 22-month-old mice is not affected by a [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]] cycle</li></ul>                                                                                                                                                                       |
| [[Research/Insights/2025-01-30 14-26-56\|2025-01-30 14-26-56]]                                                                       | <ul><li>The % of cas3+p16+ [[Research/Tags/Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)\|Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)]] increases from ~1% to ~3% in the bone marrow of 22-month-old mice at 24 hours after [[Research/Tags/Refeeding\|Refeeding]] following two consecutive [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]] cycles</li></ul>                                                                                    |
| [[Research/Insights/2025-01-30 14-28-44\|2025-01-30 14-28-44]]                                                                       | <ul><li>The enhanced [[Research/Tags/Self-Renewal\|Self-Renewal]] program of [[Research/Tags/Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)\|Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)]] from mice after 72-hour [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] is inherent to the LT-HSC cells and not related to the BM stromal niche cells</li></ul>                                                                                                      |
| [[Research/Insights/2025-01-30 14-29-17\|2025-01-30 14-29-17]]                                                                       | <ul><li>The ideal single dose for injecting [[Research/Tags/Hypoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)\|Hypoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)]] into the [[Research/Tags/Annulus Fibrosus\|Annulus Fibrosus]] of a torn [[Research/Tags/L5-S1\|L5-S1]] [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] to improve overall quality of life after 4+ years may be 35.9 million cells</li></ul>                                                                             |
| [[Research/Insights/2025-01-30 14-30-40\|2025-01-30 14-30-40]]                                                                       | <ul><li>The number of [[Research/Tags/Bone Marrow Mesenchymal Stem Cells (BMMSCs)\|Bone Marrow Mesenchymal Stem Cells (BMMSCs)]] in mouse bone marrow decreases with age</li></ul>                                                                                                                                                                                                                                     |
| [[Research/Insights/2025-01-30 14-33-50\|2025-01-30 14-33-50]]                                                                       | <ul><li>The number of [[Research/Tags/Bone Marrow Mesenchymal Stem Cells (BMMSCs)\|Bone Marrow Mesenchymal Stem Cells (BMMSCs)]] in the bone marrow decreases with age</li></ul>                                                                                                                                                                                                                                       |
| [[Research/Insights/2025-01-30 14-40-02\|2025-01-30 14-40-02]]                                                                       | <ul><li>The reduction in circulating [[Research/Tags/IGF1\|IGF1]] availability during fasting is responsible for the fasting-induced symmetric [[Research/Tags/Self-Renewal\|Self-Renewal]] of mouse [[Research/Tags/Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)\|Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)]] after 72-hour [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]]</li></ul>                                                                                          |
| [[Research/Insights/2025-01-30 14-41-07\|2025-01-30 14-41-07]]                                                                       | <ul><li>The ratio of total [[Research/Tags/Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)\|Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)]] to total bone marrow cells in mouse bone marrow is increased in mice after 72-hour [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] compared to non-fasting mice</li></ul>                                                                                                                  |
| [[Research/Insights/2025-01-30 14-43-30\|2025-01-30 14-43-30]]                                                                       | <ul><li>The ratio of [[Research/Tags/Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)\|Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)]] to total CD45+ cells increases for LT-HSCs isolated from the bone marrow of mice after 72-hour [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] mice compared to those of non-fasted mice upon 3-day co-culture with Lin-CD45- stromal cells from the bone marrow of non-fasted mice</li></ul>    |
| [[Research/Insights/2025-01-30 14-44-30\|2025-01-30 14-44-30]]                                                                       | <ul><li>The ratio of [[Research/Tags/Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)\|Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)]] to total CD45+ cells increases for LT-HSCs isolated from the BM of mice after 72-hour [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] compared to those of non-fasted mice upon 3-day co-culture with Lin-CD45- stromal cells from the bone marrow of 72-hour-fasted mice</li></ul>              |
| [[Research/Insights/2025-01-30 14-45-54\|2025-01-30 14-45-54]]                                                                       | <ul><li>The ratio of BrdU+ [[Research/Tags/Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)\|Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)]] to total bone marrow cells in mouse bone marrow is increased in mice after 72-hour [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] compared to non-fasting mice</li></ul>                                                                                                                  |
| [[Research/Insights/2025-01-30 14-46-24\|2025-01-30 14-46-24]]                                                                       | <ul><li>The number of lin-Sca1+CD45- cells in mouse bone marrow decreases with age</li></ul>                                                                                                                                                                                                                                                                |
| [[Research/Insights/2025-01-30 14-47-02\|2025-01-30 14-47-02]]                                                                       | <ul><li>The number of lin-Sca1+CD45- [[Research/Tags/Bone Marrow Mesenchymal Stem Cells (BMMSCs)\|Bone Marrow Mesenchymal Stem Cells (BMMSCs)]] in mouse bone marrow decreases with age</li></ul>                                                                                                                                                                                                                      |
| [[Research/Insights/2025-01-30 14-48-20\|2025-01-30 14-48-20]]                                                                       | <ul><li>The number of [[Research/Tags/Hypoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)\|Hypoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)]] injected into the [[Research/Tags/Annulus Fibrosus\|Annulus Fibrosus]] of a torn [[Research/Tags/L5-S1\|L5-S1]] [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] may positively correlate with overall improvement in quality of life after 4+ years</li></ul>                                                                                  |
| [[Research/Insights/2025-01-30 14-53-57\|2025-01-30 14-53-57]]                                                                       | <ul><li>The serum [[Research/Tags/IGF1-IGFBP1 Ratio\|IGF1-IGFBP1 Ratio]] is reduced by ~94% in mice during a 4-day [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]]</li></ul>                                                                                                                                                                                                                                |
| [[Research/Insights/2025-01-30 14-54-39\|2025-01-30 14-54-39]]                                                                       | <ul><li>The total number of [[Research/Tags/Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)\|Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)]] in mouse bone marrow increases by the end of 72-hour [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]]</li></ul>                                                                                                                                                                            |
| [[Research/Insights/2025-01-30 14-55-51\|2025-01-30 14-55-51]]                                                                       | <ul><li>The total number of cells in the bone marrow of mice is no different between mice at the end of 72-hour [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] vs. non-fasting mice.</li></ul>                                                                                                                                                                                       |
| [[Research/Insights/2025-01-30 14-56-06\|2025-01-30 14-56-06]]                                                                       | <ul><li>The total number of cycling [[Research/Tags/Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)\|Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)]] in mouse bone marrow increases by the end of 72-hour [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]]</li></ul>                                                                                                                                                                    |
| [[Research/Insights/2025-01-30 14-57-31\|2025-01-30 14-57-31]]                                                                       | <ul><li>There are fewer [[Research/Tags/Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)\|Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)]] [[Research/Tags/Senescent Cells\|Senescent Cells]] in the bone marrow of mice 24 hours after [[Research/Tags/Refeeding\|Refeeding]] following two consecutive [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]] cycles</li></ul>                                                                                                             |
| [[Research/Insights/2025-01-30 14-58-12\|2025-01-30 14-58-12]]                                                                       | <ul><li>Two consecutive monthly [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]] cycles can reduce the number of [[Research/Tags/Senescent Cells\|Senescent Cells]] throughout the body</li></ul>                                                                                                                                                                                                          |
| [[Research/Insights/2025-01-30 15 28 41\|2025-01-30 15 28 41]]                                                                       | <ul><li>[[Research/Tags/Urolithin A\|Urolithin A]] reduces the progression of [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] degeneration at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 8 weeks of age compared to rats not fed urolithin A</li></ul>                                                                                                                       |
| [[Research/Insights/2025-01-30 15-00-30\|2025-01-30 15-00-30]]                                                                       | <ul><li>Undergoing a 4-day [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]] once every two weeks starting at 16 months of age increases the number of BrdU+ lin-Sca1+CD45- BM cells at 7 days after [[Research/Tags/Refeeding\|Refeeding]] following [[Research/Tags/BrdU\|BrdU]] treatment in 20.5-month-old mice compared to age-matched controls</li></ul>                                                            |
| [[Research/Insights/2025-01-30 15-01-49\|2025-01-30 15-01-49]]                                                                       | <ul><li>Undergoing a 4-day [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]] once every two weeks starting at 16 months of age increases the number of proliferating [[Research/Tags/Bone Marrow Mesenchymal Stem Cells (BMMSCs)\|Bone Marrow Mesenchymal Stem Cells (BMMSCs)]] in mouse bone marrow at 7 days after [[Research/Tags/Refeeding\|Refeeding]] in 20.5-month-old mice compared to age-matched controls</li></ul>                                    |
| [[Research/Insights/2025-01-30 15-04-10\|2025-01-30 15-04-10]]                                                                       | <ul><li>Undergoing a 4-day [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]] once every two weeks starting at 16 months of age increases the number of proliferating [[Research/Tags/Bone Marrow Mesenchymal Stem Cells (BMMSCs)\|Bone Marrow Mesenchymal Stem Cells (BMMSCs)]] in mouse bone marrow at 7 days after [[Research/Tags/Refeeding\|Refeeding]]</li></ul>                                                                                            |
| [[Research/Insights/2025-01-30 15-04-37\|2025-01-30 15-04-37]]                                                                       | <ul><li>Undergoing a 4-day [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]] once every two weeks starting at 16 months of age increases the number of proliferating lin-Sca1+CD45- bone marrow cells at 7 days after [[Research/Tags/Refeeding\|Refeeding]] in 20.5-month-old mice compared to age-matched controls</li></ul>                                                                        |
| [[Research/Insights/2025-01-30 15-05-43\|2025-01-30 15-05-43]]                                                                       | <ul><li>Undergoing a 4-day [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]] once every two weeks starting at 16 months of age increases the number of proliferating lin-Sca1+CD45- [[Research/Tags/Bone Marrow Mesenchymal Stem Cells (BMMSCs)\|Bone Marrow Mesenchymal Stem Cells (BMMSCs)]] in mouse bone marrow at 7 days after [[Research/Tags/Refeeding\|Refeeding]] in 20.5-month-old mice compared to age-matched controls</li></ul>                     |
| [[Research/Insights/2025-01-30 15-06-32\|2025-01-30 15-06-32]]                                                                       | <ul><li>Undergoing a 4-day [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]] once every two weeks starting at 16 months of age increases the ratio of BrdU+ lin-Sca1+CD45- cells to total bone marrow cells at 7 days after [[Research/Tags/Refeeding\|Refeeding]] following [[Research/Tags/BrdU\|BrdU]] treatment in 20.5-month-old mice compared to age-matched controls</li></ul>                                     |
| [[Research/Insights/2025-01-30 15-06-49\|2025-01-30 15-06-49]]                                                                       | <ul><li>Undergoing a 4-day [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]] once every two weeks starting at 16 months of age increases the ratio of lin-Sca1+CD45- [[Research/Tags/Bone Marrow Mesenchymal Stem Cells (BMMSCs)\|Bone Marrow Mesenchymal Stem Cells (BMMSCs)]] to total bone marrow cells at 7 days after [[Research/Tags/Refeeding\|Refeeding]] in 20.5-month-old mice compared to age-matched controls</li></ul>                              |
| [[Research/Insights/2025-01-30 15-07-48 (WIP)\|2025-01-30 15-07-48 (WIP)]]                                                           | <ul><li>Undergoing a [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]] cycle causes an increase in total [[Research/Tags/Bone Marrow Mesenchymal Stem Cells (BMMSCs)\|Bone Marrow Mesenchymal Stem Cells (BMMSCs)]] in mouse bone marrow</li></ul>                                                                                                                                                                                      |
| [[Research/Insights/2025-01-30 15-11-44\|2025-01-30 15-11-44]]                                                                       | <ul><li>[[Research/Tags/Urolithin A\|Urolithin A]] can reduce the pain response to a 1g Von Frey filament at a dose of 250 mg/kg/day, but not 50 mg/kg/day, compared to control when taken for 8 weeks after the induction of experimental [[Research/Tags/Osteoarthritis\|Osteoarthritis]] at 4 months of age</li></ul>                                                                                             |
| [[Research/Insights/2025-01-30 15-14-32\|2025-01-30 15-14-32]]                                                                       | <ul><li>[[Research/Tags/Urolithin A\|Urolithin A]] increases the [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] [[Research/Tags/Aggrecan\|Aggrecan]] fluorescence at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 4-6 months of age compared to rats not fed urolithin A</li></ul>                                                                                                                    |
| [[Research/Insights/2025-01-30 15-15-20\|2025-01-30 15-15-20]]                                                                       | <ul><li>[[Research/Tags/Urolithin A\|Urolithin A]] increases the [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] [[Research/Tags/Collagen Type II\|Collagen Type II]] fluorescence at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 4-6 months of age compared to rats not fed urolithin A</li></ul>                                                                                                            |
| [[Research/Insights/2025-01-30 15-17-08\|2025-01-30 15-17-08]]                                                                       | <ul><li>[[Research/Tags/Urolithin A\|Urolithin A]] increases the [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] disc height index at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 4-6 months of age compared to rats not fed urolithin A</li></ul>                                                                                                                            |
| [[Research/Insights/2025-01-30 15-18-26\|2025-01-30 15-18-26]]                                                                       | <ul><li>[[Research/Tags/Urolithin A\|Urolithin A]] increases the cell number in non-calcified knee [[Research/Tags/Cartilage\|Cartilage]] of mice at a dose of 250 mg/kg/day, but not 50 mg/kg/day, compared to control when taken for 8 weeks after the induction of experimental [[Research/Tags/Osteoarthritis\|Osteoarthritis]] at 4 months of age</li></ul>                                                                              |
| [[Research/Insights/2025-01-30 15-18-57\|2025-01-30 15-18-57]]                                                                       | <ul><li>[[Research/Tags/Urolithin A\|Urolithin A]] may reduce knee [[Research/Tags/Sinovitis\|Sinovitis]] at a dose of 250 mg/kg/day, but not 50 mg/kg/day, compared to control when taken for 8 weeks after the induction of experimental [[Research/Tags/Osteoarthritis\|Osteoarthritis]] at 4 months of age</li></ul>                                                                                                                      |
| [[Research/Insights/2025-01-30 15-20-59\|2025-01-30 15-20-59]]                                                                       | <ul><li>[[Research/Tags/Urolithin A\|Urolithin A]] may reduce the pain from knee [[Research/Tags/Osteoarthritis\|Osteoarthritis]] in mice at a dose of either 250 mg/kg/day or 50 mg/kg/day when taken for 8 weeks after the induction of experimental [[Research/Tags/Osteoarthritis\|Osteoarthritis]] at 4 months of age</li></ul>                                                                                                               |
| [[Research/Insights/2025-01-30 15-21-19\|2025-01-30 15-21-19]]                                                                       | <ul><li>[[Research/Tags/Urolithin A\|Urolithin A]] may reduce the pain response to a 4g Von Frey filament at a dose of 250 mg/kg/day, but not 50 mg/kg/day, compared to control when taken for 4 weeks after the induction of experimental [[Research/Tags/Osteoarthritis\|Osteoarthritis]] at 4 months of age</li></ul>                                                                                             |
| [[Research/Insights/2025-01-30 15-23-01\|2025-01-30 15-23-01]]                                                                       | <ul><li>[[Research/Tags/Urolithin A\|Urolithin A]] may reduce the pain response to a 4g Von Frey filament at a dose of either 250 mg/kg/day or 50 mg/kg/day compared to control when taken for 8 weeks after the induction of experimental [[Research/Tags/Osteoarthritis\|Osteoarthritis]] at 4 months of age</li></ul>                                                                                             |
| [[Research/Insights/2025-01-30 15-23-29\|2025-01-30 15-23-29]]                                                                       | <ul><li>[[Research/Tags/Urolithin A\|Urolithin A]] reduces markers of the progression of knee [[Research/Tags/Osteoarthritis\|Osteoarthritis]] at a dose of 250 mg/kg/day, but not 50 mg/kg/day, compared to control when taken for 8 weeks after the induction of experimental [[Research/Tags/Osteoarthritis\|Osteoarthritis]] at 4 months of age</li></ul>                                                                                      |
| [[Research/Insights/2025-01-30 15-24-17\|2025-01-30 15-24-17]]                                                                       | <ul><li>[[Research/Tags/Urolithin A\|Urolithin A]] reduces the [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] [[Research/Tags/Pfirrmann Grade\|Pfirrmann Grade]] at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 8 weeks of age compared to rats not fed urolithin A</li></ul>                                                                                                                               |
| [[Research/Insights/2025-01-30 15-25-18\|2025-01-30 15-25-18]]                                                                       | <ul><li>[[Research/Tags/Urolithin A\|Urolithin A]] reduces the [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] histological score at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 8 weeks of age compared to rats not fed urolithin A</li></ul>                                                                                                                                |
| [[Research/Insights/2025-01-30 15-26-59\|2025-01-30 15-26-59]]                                                                       | <ul><li>[[Research/Tags/Urolithin A\|Urolithin A]] reduces the knee OARSI score of mice at a dose of 250 mg/kg/day, but not 50 mg/kg/day, compared to control when taken for 8 weeks after the induction of experimental [[Research/Tags/Osteoarthritis\|Osteoarthritis]] at 4 months of age</li></ul>                                                                                                               |
| [[Research/Insights/2025-01-30 15-28-05\|2025-01-30 15-28-05]]                                                                       | <ul><li>[[Research/Tags/Urolithin A\|Urolithin A]] reduces the number of TUNEL-positive cells in the [[Research/Tags/Nucleus Pulposus\|Nucleus Pulposus]] at a dose of 25 mg/kg/day when taken for 4 weeks after an [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] puncture at 8 weeks of age compared to rats not fed urolithin A</li></ul>                                                                                            |
| [[Research/Insights/2025-01-30 15-30-53\|2025-01-30 15-30-53]]                                                                       | <ul><li>[[Research/Tags/Urolithin A\|Urolithin A]] reduces the serum levels of [[Research/Tags/Matrix Metalloproteinase-3 (MMP3)\|Matrix Metalloproteinase-3 (MMP3)]] in mice at a dose of 250 mg/kg/day, but not 50 mg/kg/day, compared to control when taken for 8 weeks after the induction of experimental [[Research/Tags/Osteoarthritis\|Osteoarthritis]] at 4 months of age</li></ul>                                                                          |
| [[Research/Insights/2025-01-30 15-31-32\|2025-01-30 15-31-32]]                                                                       | <ul><li>[[Research/Tags/Urolithin A\|Urolithin A]] slows the increase in histologic score at a dose of 25 mg/kg/day when taken for 4 weeks after an [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] puncture at 12 weeks of age compared to rats not fed urolithin A</li></ul>                                                                                                                           |
| [[Research/Insights/2025-01-30 15-32-27\|2025-01-30 15-32-27]]                                                                       | <ul><li>[[Research/Tags/Urolithin A\|Urolithin A]] slows the progression in [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] [[Research/Tags/Pfirrmann Grade\|Pfirrmann Grade]] at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 4-6 months of age compared to rats not fed urolithin A</li></ul>                                                                                                               |
| [[Research/Insights/2025-01-30 15-33-56\|2025-01-30 15-33-56]]                                                                       | <ul><li>[[Research/Tags/Urolithin A\|Urolithin A]] slows the progression of [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] degeneration at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 12 weeks of age compared to rats not fed urolithin A</li></ul>                                                                                                                        |
| [[Research/Insights/2025-01-30 15-34-20\|2025-01-30 15-34-20]]                                                                       | <ul><li>[[Research/Tags/Urolithin A\|Urolithin A]] slows the progression of [[Research/Tags/Pfirrmann Grade\|Pfirrmann Grade]] at a dose of 25 mg/kg/day when taken for 4 weeks after an [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] puncture at 12 weeks of age compared to rats not fed urolithin A</li></ul>                                                                                                                     |
| [[Research/Insights/2025-01-30 15-34-35\|2025-01-30 15-34-35]]                                                                       | <ul><li>[[Research/Tags/Urolithin A\|Urolithin A]] slows the progression of [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] degeneration at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 4-6 months of age compared to rats not fed urolithin A</li></ul>                                                                                                                      |
| [[Research/Insights/2025-01-30 15-35-56\|2025-01-30 15-35-56]]                                                                       | <ul><li>[[Research/Tags/Urolithin A\|Urolithin A]] slows the progressive loss of [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] height at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 12 weeks of age compared to rats not fed Urolithin A</li></ul>                                                                                                                         |
| [[Research/Insights/2025-01-30 15-36-46\|2025-01-30 15-36-46]]                                                                       | <ul><li>Whole-body expression of [[Research/Tags/p16\|p16]] increases in mice as they age</li></ul>                                                                                                                                                                                                                                                                            |
| [[Research/Insights/2025-01-30 15-37-02\|2025-01-30 15-37-02]]                                                                       | <ul><li>[[Research/Tags/Urolithin A\|Urolithin A]] slows the reduction in [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] histological score at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 4-6 months of age compared to rats not fed urolithin A</li></ul>                                                                                                                  |
| [[Research/Insights/2025-01-30 15-37-51\|2025-01-30 15-37-51]]                                                                       | <ul><li>Whole-body expression of [[Research/Tags/p16\|p16]] is reduced in 11-month-old mice at the end of a second consecutive monthly [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]] cycle</li></ul>                                                                                                                                                                                        |
| [[Research/Insights/2025-01-30 15-38-45\|2025-01-30 15-38-45]]                                                                       | <ul><li>[[Research/Tags/p16\|p16]] expression is not reduced in [[Research/Tags/Short-Term Hematopoietic Stem Cells (ST-HSCs)\|Short-Term Hematopoietic Stem Cells (ST-HSCs)]] or [[Research/Tags/Multipotent Progenitors (MPPs)\|Multipotent Progenitors (MPPs)]] in the bone marrow of 22-month-old mice at 24 hours after [[Research/Tags/Refeeding\|Refeeding]] following two consecutive [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]] cycles</li></ul>                                                                    |
| [[Research/Insights/2025-01-30 15-39-20\|2025-01-30 15-39-20]]                                                                       | <ul><li>[[Research/Tags/p16\|p16]] expression is reduced in [[Research/Tags/Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)\|Bone Marrow Long-Term Hematopoietic Stem Cells (BM LT-HSCs)]] in the bone marrow of 22-month-old mice at 24 hours after [[Research/Tags/Refeeding\|Refeeding]] following two consecutive [[Research/Tags/Fasting-Mimicking Diet (FMD)\|Fasting-Mimicking Diet (FMD)]] cycles</li></ul>                                                                                                |
| [[Research/Insights/Muscle stem cells have ~40% reduced mitochondrial content (number and/2025-01-20 18-42-42\|2025-01-20 18-42-42]] | <ul><li>[[Research/Tags/Muscle Stem Cells (MuSCs, Satellite Stem Cells)\|Muscle Stem Cells (MuSCs, Satellite Stem Cells)]] have ~40% reduced content of [[Research/Tags/Mitochondria\|Mitochondria]] (number and/or size) in mice at the end of 2.5-day [[Research/Tags/Prolonged Fasting\|Prolonged Fasting]] compared to non-fasted mice as assessed by [[Research/Tags/MitoTracker\|MitoTracker]]</li></ul>                                                                                                     |

{ .block-language-dataview}
